secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2024-01-11T23:59:59+00:00
Accession:  0001654954-24-000467
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catheter Precision reports preliminary 2023 revenue $442K, net loss $72.4M including $61M goodwill impairment
--------------------------------------------------------------------------------

- Q4 2023 revenue ~$129K; full-year revenue ~$442K.
- Preliminary net loss: Q4 ~($2.5M), FY ~($72.4M) includes $61M one-time goodwill impairment.
- Cash on hand $3.6M; shareholders equity $19.4M as of Dec 31, 2023.
- Launched LockeT closure product; enrolled 100+ patients in Phase I study; IRB approved Phase II.
- VIVO active in six European countries; IP portfolio expanded to 50 patents worldwide.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000165495424000467/0001654954-24-000467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000165495424000467/rmed_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-000467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer